Cart
sales@molnova.com
CP-466722
CAS No. 1080622-86-1
CP-466722( CP466722 | CP 466722 )
Catalog No. M10322 CAS No. 1080622-86-1
A poten and selective ATM inhibitor without effect on ATR kinase; does not inhibit PI3K, PI3K-like protein kinases or Abl kinase and disrupts ATM-dependent cell cycle checkpoints in cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 40 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 105 | In Stock |
|
| 25MG | 174 | In Stock |
|
| 50MG | 281 | In Stock |
|
| 100MG | 455 | In Stock |
|
| 500MG | 1017 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCP-466722
-
NoteResearch use only, not for human use.
-
Brief DescriptionA poten and selective ATM inhibitor without effect on ATR kinase; does not inhibit PI3K, PI3K-like protein kinases or Abl kinase and disrupts ATM-dependent cell cycle checkpoints in cells.
-
DescriptionA poten and selective ATM inhibitor without effect on ATR kinase; does not inhibit PI3K, PI3K-like protein kinases or Abl kinase and disrupts ATM-dependent cell cycle checkpoints in cells.
-
In Vitro——
-
In Vivo——
-
SynonymsCP466722 | CP 466722
-
PathwayCell Cycle/DNA Damage
-
TargetATM/ATR
-
RecptorATM
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1080622-86-1
-
Formula Weight349.3467
-
Molecular FormulaC17H15N7O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 7 mg/mL (Need warming)
-
SMILESCOC1=C(C=C2C(=C1)C(=NC=N2)N3C(=NC(=N3)C4=CC=CC=N4)N)OC
-
Chemical Name1H-1,2,4-Triazol-5-amine, 1-(6,7-dimethoxy-4-quinazolinyl)-3-(2-pyridinyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rainey MD, et al. Cancer Res. 2008 Sep 15;68(18):7466-74.
molnova catalog
related products
-
AZD1390
AZD1390 (AZD-1390) is a novel potent, selective, orally available and CNS penetrant ATM inhibitor with IC50 of 0.78 nM.Brain Cancer,Phase 1 Clinical
-
KU 59403
KU 59403 is a selective and potent ATM inhibitor with antitumor and anticancer activity, inhibits ATM, DNA-PK and PI3K, and is often used in combination therapy with PARP or ATR inhibitors to slow the progression of cancer.
-
AZ-31
A potent, highly selective and orally active ATM inhibitor with enzyme IC50 of <1.2 nM, cell IC50 of 46 nM.
